Niu, F.-W., Zhang, Y.-J., Li, K. and Zhang, M.-S. 2014. Nobiletin acts as a potential anticancer agent against osteosarcoma by regulating ERK and AKT signaling pathways. Bangladesh Journal of Pharmacology. 9, 3 (Sep. 2014), 406–412. DOI:https://doi.org/10.3329/bjp.v9i3.19567.